Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus

Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study

(2014) Fang Fang Jiao et al.   Cardiovascular Diabetology

Residual macrovascular risk in 2013: what have we learned?

(2014) Jean-Charles Fruchart et al.   Cardiovascular Diabetology

Global Guideline for Type 2 Diabetes

(2014)   DIABETES RESEARCH AND CLINICAL PRACTICE

Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes

(2013) Sheldon Greenfield   ANNALS OF INTERNAL MEDICINE

The association of obesity with cardiovascular events in patients with peripheral artery disease

(2013) Oliver Cronin et al.   ATHEROSCLEROSIS

Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study

(2013) Giuseppe Penno et al.   Cardiovascular Diabetology

Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: a 20-year follow up

(2013) Salvatore Novo et al.   Cardiovascular Diabetology

Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus

(2013) Jun Hata et al.   CIRCULATION

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial

(2013) et al.   EUROPEAN HEART JOURNAL

Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register

(2013) B Zethelius et al.   European Journal of Preventive Cardiology

HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?

(2013) Bernd Kowall et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Health Care Costs in People With Diabetes and Their Association With Glycemic Control and Kidney Function

(2012) K. A. McBrien et al.   DIABETES CARE

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis

(2012) W. Rathmann et al.   DIABETES OBESITY & METABOLISM

Current controversies in the use of haemoglobin A1c

(2012) M. J. L. Hare et al.   JOURNAL OF INTERNAL MEDICINE

Diabetes in Older Adults: A Consensus Report

(2012) M. Sue Kirkman et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials

(2011) M. Volpe et al.   AMERICAN JOURNAL OF HYPERTENSION

Implications of Using Hemoglobin A1C for Diagnosing Diabetes Mellitus

(2011) Samir Malkani et al.   AMERICAN JOURNAL OF MEDICINE

High-Normal HbA1c Is a Strong Predictor of Type 2 Diabetes in the General Population

(2011) E. Bonora et al.   DIABETES CARE

Glycemic Control, Complications, and Death in Older Diabetic Patients: The Diabetes and Aging Study

(2011) E. S. Huang et al.   DIABETES CARE

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?

(2010) Sripal Bangalore et al.   CIRCULATION

Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study

(2010) M. L. Norgaard et al.   DIABETOLOGIA

Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

(2010) Craig J Currie et al.   LANCET

Prediction of Mortality in Patients Undergoing Maintenance Hemodialysis by Charlson Comorbidity Index Using ICD-10 Database

(2010) Je-Wook Chae et al.   NEPHRON CLINICAL PRACTICE

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial

(2009) S. Zoungas et al.   DIABETES CARE

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

(2009) E. Ferrannini et al.   DIABETES OBESITY & METABOLISM

The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure

(2008) Hertzel C. Gerstein   ARCHIVES OF INTERNAL MEDICINE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE